These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6636131)

  • 1. [Experiences with Lysodren therapy of Cushing's syndrome in the dog (1)].
    Opitz M; Lettow E; Loppnow H; Grevel V
    Tierarztl Prax; 1983; 11(3):369-84. PubMed ID: 6636131
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experiences with Lysodren treatment of Cushing's syndrome in dogs].
    Opitz M; Lettow E; Loppnow H; Grevel V
    Tierarztl Prax; 1983; 11(4):507-20. PubMed ID: 6658774
    [No Abstract]   [Full Text] [Related]  

  • 3. [Laboratory parameters for the control of the course of therapy of canine Cushing's syndrome].
    Reusch C; Hähnle B
    Tierarztl Prax; 1991 Feb; 19(1):102-6. PubMed ID: 1646492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Case presentation in small animal medicine].
    Gfeller G; Reusch C
    Schweiz Arch Tierheilkd; 1998; 140(9):375-9. PubMed ID: 9757786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. o,p'-DDD (mitotane) treatment of canine pituitary-dependent hyperadrenocorticism.
    Peterson ME
    J Am Vet Med Assoc; 1983 Mar; 182(5):527-8. PubMed ID: 6300010
    [No Abstract]   [Full Text] [Related]  

  • 6. [Formal pathogenesis, average age and breed distribution in the comparison of 61 Lysodren-treated and 36 untreated cases of canine hyperadrenocorticism which were dissected in the years 1975 to 1991 at the Institute for Veterinary Pathology of the Free University of Berlin].
    Nothelfer HB; Weinhold K
    Berl Munch Tierarztl Wochenschr; 1992 Sep; 105(9):305-11. PubMed ID: 1417721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. o,p-DDD in the treatment of Cushing's disease.
    Nash AS; Bogan JA
    Vet Rec; 1978 May; 102(21):470. PubMed ID: 664205
    [No Abstract]   [Full Text] [Related]  

  • 8. The treatment of Cushing's disease in the dog.
    Lavelle RB
    Vet Rec; 1976 May; 98(20):406. PubMed ID: 936449
    [No Abstract]   [Full Text] [Related]  

  • 9. Problems associated with medical therapy of canine hyperadrenocorticism.
    Nichols R
    Probl Vet Med; 1990 Dec; 2(4):551-6. PubMed ID: 2134073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoadrenocorticism following therapy with o,p-DDD for hyperadrenocorticism in four dogs.
    Willard MD; Schall WD; Nachreiner RF; Shelton DG
    J Am Vet Med Assoc; 1982 Mar; 180(6):638-41. PubMed ID: 7068503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical treatment of pituitary-dependent hyperadrenocorticism in dogs.
    Peterson ME; Kintzer PP
    Semin Vet Med Surg Small Anim; 1994 Aug; 9(3):127-31. PubMed ID: 7938931
    [No Abstract]   [Full Text] [Related]  

  • 12. Cushing's syndrome in the dog.
    Siegel ET; Kelly DF; Berg P
    J Am Vet Med Assoc; 1970 Dec; 157(12):2081-90. PubMed ID: 4320508
    [No Abstract]   [Full Text] [Related]  

  • 13. Medical treatment of canine pituitary-dependent hyperadrenocorticism (Cushing's disease).
    Peterson ME
    Vet Clin North Am Small Anim Pract; 2001 Sep; 31(5):1005-14, viii. PubMed ID: 11570123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of mitotane therapy in dogs with pituitary dependent Cushing syndrome on the adrenal gland size--an ultrasonographic study].
    Hörauf A; Reusch C
    Schweiz Arch Tierheilkd; 1999; 141(5):239-45. PubMed ID: 10354742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased approvals--myth or reality.
    Gingerich DA
    J Am Vet Med Assoc; 1993 May; 202(10):1703-7;discussion 1713-7. PubMed ID: 8514589
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of Cushing's sundrome in the dog with an adrenocorticolytic agent (o,p'DDD).
    Schechter RD; Stabenfeldt GH; Gribble DH; Ling GV
    J Am Vet Med Assoc; 1973 Apr; 162(8):629-39. PubMed ID: 4697358
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypophyseal-adrenocortical function in experimental iatrogenic canine Cushing's syndrome.
    Komiyama N; Tsumagari S; Ohba S; Takagi K; Satoh S; Takeishi M
    J Vet Med Sci; 1991 Apr; 53(2):351-3. PubMed ID: 1650606
    [No Abstract]   [Full Text] [Related]  

  • 18. Diagnosis and management of concurrent diabetes mellitus and hyperadrenocorticism in thirty dogs.
    Peterson ME; Nesbitt GH; Schaer M
    J Am Vet Med Assoc; 1981 Jan; 178(1):66-9. PubMed ID: 7009530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes mellitus in dogs: a review of initial evaluation, immediate and long-term management, and outcome.
    Ling GV; Lowenstine LJ; Pulley LT; Kaneko JJ
    J Am Vet Med Assoc; 1977 Mar; 170(5):521-30. PubMed ID: 557467
    [No Abstract]   [Full Text] [Related]  

  • 20. Effective treatment with mitotane for a canine case of presumed ectopic Cushing's syndrome-related pheochromocytoma.
    Miura K; Sunahara H; Sakai Y; Isshiki S; Hasegawa M; Oda M
    Open Vet J; 2022; 12(5):762-767. PubMed ID: 36589399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.